For example, it would seem impractical to use miRNA expression to obtain information similar to the well-established ER/PR/HER2 status in breast cancer, but miRNA expression could be of use in cancer cells or other tumor compartments to refine the characterization and prognostic indications based on ER/PR/HER2 status. This evidence concerns the gene ERBB2 and neoplasm.